Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL14829650

O=C(O)C(F)(F)F.c1ccc(Oc2ccc(C3COCCN3)cc2)cc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.43
▸ SCN3A Q9NY46 2/20 0.43
▸ CTSK P43235 1/20 0.38
▸ KDM1A O60341 5/20 0.37
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ S1PR4 O95977 2/20 0.36
▸ S1PR1 P21453 2/20 0.36
▸ S1PR3 Q99500 2/20 0.36
▸ S1PR5 Q9H228 2/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ METTL3 Q86U44 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ PDK1 Q15118 1/20 0.34
▸ PDK2 Q15119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL14829349 0.88 KDM1A (0.44) CTSKKDM1AMETTL3
SCHEMBL14839568 0.88 KCNH2 (0.43) KCNH2SCN3ACTSKKDM1ACYP19A1
Trifluoroacetic Acid SCHEMBL14830108 0.83 SLC6A2 (0.41) KCNH2KDM1A
Trifluoroacetic Acid SCHEMBL14837280 0.83 KDM1A (0.47) CTSKKDM1AMETTL3
Trifluoroacetic Acid SCHEMBL14839831 0.82 KDM1A (0.47) CTSKKDM1AMETTL3
Trifluoroacetic Acid SCHEMBL14830111 0.82 CTSK (0.38) CTSKKDM1AHDAC1METTL3HDAC6
SCHEMBL14837281 0.81 CTSK (0.36) CTSKKDM1AS1PR4S1PR1S1PR3
Trifluoroacetic Acid SCHEMBL14829608 0.77 CTSK (0.39) CTSKHDAC1NPC1RAB9AHDAC7
Trifluoroacetic Acid SCHEMBL14829510 0.77 PRKACA (0.44) CTSKKDM1A
SCHEMBL19580550 0.76 NISCH (0.40) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751088-B1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMA (US) 2016-04-13 — — EP disclosed
EP-2751088-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2014-07-09 — — EP disclosed
US-8765751-B2 Compounds useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-07-01 — — US disclosed
US-20130089624-A1 Compounds Useful as Inhibitors of ATR Kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-11 — — US disclosed
WO-2013049719-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130089624-A1 Compounds Useful as Inhibitors of ATR Kinase ATR, CHEK1, PLK1 KCNH2 2933/4885SCN3A 2938/4885CTSK 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback